These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30093304)

  • 21. Prescribing efficiency of proton pump inhibitors in China: influence and future directions.
    Zeng W; Finlayson AE; Shankar S; de Bruyn W; Godman B
    BMC Health Serv Res; 2015 Jan; 15():11. PubMed ID: 25609265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship.
    Dutta AK; Jain A; Jearth V; Mahajan R; Panigrahi MK; Sharma V; Goenka MK; Kochhar R; Makharia G; Reddy DN; Kirubakaran R; Ahuja V; Berry N; Bhat N; Dutta U; Ghoshal UC; Jain A; Jalihal U; Jayanthi V; Kumar A; Nijhawan S; Poddar U; Ramesh GN; Singh SP; Zargar S; Bhatia S
    Indian J Gastroenterol; 2023 Oct; 42(5):601-628. PubMed ID: 37698821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRAZILIAN CLINICAL GUIDELINE FOR THE THERAPEUTIC MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE (BRAZILIAN FEDERATION OF GASTROENTEROLOGY, FBG).
    Moraes-Filho JPP; Domingues G; Chinzon D;
    Arq Gastroenterol; 2024; 61():e23154. PubMed ID: 38511797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why do GPs continue inappropriate hospital prescriptions of proton pump inhibitors? A qualitative study.
    Wermeling M; Himmel W; Behrens G; Ahrens D
    Eur J Gen Pract; 2014 Sep; 20(3):174-80. PubMed ID: 24219345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.
    Giannini EG; Crespi M; Djahandideh A; Demarzo MG; Moscatelli A; Bodini G; Furnari M; Marabotto E; Plaz Torres MC; Zentilin P; Savarino V
    Dig Liver Dis; 2020 Aug; 52(8):862-868. PubMed ID: 32505566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence.
    Solem C; Mody R; Stephens J; Macahilig C; Gao X
    J Am Pharm Assoc (2003); 2014; 54(2):144-53. PubMed ID: 24632930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.
    Tack J; Louis E; Persy V; Urbain D
    Acta Gastroenterol Belg; 2013 Dec; 76(4):393-402. PubMed ID: 24592542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastroenterology for the Internist.
    Dunbar KB
    Med Clin North Am; 2019 Jan; 103(1):xvii-xviii. PubMed ID: 30466680
    [No Abstract]   [Full Text] [Related]  

  • 31. Practical considerations in the management of proton-pump inhibitors.
    Aguilera-Castro L; Martín-de-Argila-dePrados C; Albillos-Martínez A
    Rev Esp Enferm Dig; 2016 Mar; 108(3):145-53. PubMed ID: 26666270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource.
    Pollock K; Grime J
    Soc Sci Med; 2000 Dec; 51(12):1827-39. PubMed ID: 11128270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton Pump Inhibitor Prescribing and Monitoring Patterns Among Gastroenterology Practitioners.
    Leiman DA; Ravi K; Freedberg DE; Gyawali CP
    J Clin Gastroenterol; 2022 Aug; 56(7):571-575. PubMed ID: 34608025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
    J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the prescription of proton pump inhibitors in persons aged 75years and older in a geriatric acute-care unit].
    Dipanda M; Pioro L; Buttard M; d'Athis P; Asgassou S; Putot S; Deïdda M; Laborde C; Putot A; Manckoundia P
    Therapie; 2017 Dec; 72(6):669-675. PubMed ID: 28939010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
    Tjon JA; Pe M; Soscia J; Mahant S
    Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safe use of proton-pump inhibitors.
    Martín de Argila de Prados C; López Cardona J; Argüelles-Arias F
    Rev Esp Enferm Dig; 2023 Sep; 115(9):475-479. PubMed ID: 37522310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost and cost-effectiveness of PPIs--GP perspectives and responses to a prescribing dilemma and their implications for the development of patient-centred healthcare.
    Pollock K; Grime J
    Eur J Gen Pract; 2003 Dec; 9(4):126-33, 140. PubMed ID: 14733400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.